Canaccord Genuity Reiterates a 'Buy' on EnteroMedics (ETRM); Positive Notes From The Road

Article Stock Quotes (1) Comments (0)

Canaccord Genuity reiterates a 'Buy' on EnteroMedics (NASDAQ: ETRM) price target of $5.00.

Analyst, William J. Plovanic, said, "We are reiterating our rating on shares of EnteroMedics. We recently traveled with management from EnteroMedics and came away with more clarity regarding 2012 catalysts, the OUS commercialization efforts, and regulatory US regulatory status."

For an analyst ratings summary and ratings history on EnteroMedics click here. For more ratings news on EnteroMedics click here.

Shares of EnteroMedics closed at $3.28 yesterday, with a 52 week range of $1.52-$3.77.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• KeyBank Upgrades MDC Holdings (MDC); Cuts PulteGroup (PHM) & Ryland Group (RYL)
• NetApp (NTAP) Post Solid Q4, Numbers Bumped - Needham & Company
• UPDATE: UBS Downgrades Carnival (CCL) to Neutral; Worst May Not Be Behind

Create E-mail Alert Related Categories

Analyst Comments

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?